Latest News
Featured News
Q&A with Scancell CMO Nermeen Varawalla
Could you tell us a bit about your background and what attracted you to Scancell? Given my educational background, which includes an MD in clinical medicine, DPhil (Oxon) in molecular medicine and INSEAD MBA, along with extensive leadership and clinical development...
Select the category
Preliminary Results for the year ended 30 April 2023
Update on Final Results
Scancell to present at the 2023 World Vaccine Congress Europe
Block Listing Six Monthly Return
Change of Date for Final Results and Investor Presentation
Notice of Final Results and Investor Presentation
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.